BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 6, 2004
View Archived Issues
Biomira Reports Phase IIb Data In Lung Cancer; Stock Rockets
Biomira Inc. watched its stock more than double Friday following positive Phase IIb data of its BLP25 liposome vaccine that showed a huge survival benefit for Stage IIIB non-small-cell lung cancer patients. (BioWorld Today)
Read More
After Four Years, Thompson Steps Down As HHS Head
Read More
BioSante Affected By FDA Panel Vote On P&G Product
Read More
Still Fighting, Genta Acquires Phase I Antisense Drug Rights
Read More
Other News To Note
Read More
Appointments And Advancements
Read More